mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-07 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-07 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-07 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-07 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-07 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-07 |
mRNA |
QL-XI-92 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
2e-07 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-07 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-07 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-07 |